Effects of psychoactive drugs on cellular bioenergetic pathways.


Journal

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
ISSN: 1814-1412
Titre abrégé: World J Biol Psychiatry
Pays: England
ID NLM: 101120023

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 17 4 2020
medline: 14 8 2021
entrez: 17 4 2020
Statut: ppublish

Résumé

To investigate the actions of lithium, valproate, lamotrigine and quetiapine on bioenergetic pathways in cultured NT2-N neuronal-like cells and C8-B4 microglial cells. NT2-N and C8-B4 cells were cultured and treated with lithium (2.5 mM), valproate (0.5 mM), quetiapine (0.05 mM) or lamotrigine (0.05 mM) for 24 hours. Gene expression and the mitochondrial bioenergetic profile were measured in both cell lines. In NT2-N cells, valproate increased oxidative phosphorylation (OXPHOS) gene expression, mitochondrial uncoupling and maximal respiratory capacity, while quetiapine decreased OXPHOS gene expression and respiration linked to ATP turnover, as well as decreasing the expression of genes in the citric acid cycle. Lamotrigine decreased OXPHOS gene expression but had no effect on respiration, while lithium reduced the expression of genes in the citric acid cycle. In C8-B4 cells, valproate and lithium increased OXPHOS gene expression, and valproate increased basal respiratory rate and maximal and spare respiratory capacities. In contrast, quetiapine significantly reduced basal respiratory rate and maximal and spare respiratory capacities. Overall our data suggest that some drugs used to treat neuropsychiatric and affective disorders have actions on a range of cellular bioenergetic processes, which could impact their effects in patients.

Identifiants

pubmed: 32295468
doi: 10.1080/15622975.2020.1755450
doi:

Substances chimiques

Psychotropic Drugs 0
Quetiapine Fumarate 2S3PL1B6UJ
Valproic Acid 614OI1Z5WI

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-93

Auteurs

Chiara C Bortolasci (CC)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.
IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.

Briana Spolding (B)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.
IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.

Srisaiyini Kidnapillai (S)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.

Mark F Richardson (MF)

Genomics Centre, School of Life and Environmental Sciences, Deakin University, Geelong, Australia.

Nina Vasilijevic (N)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.

Sheree D Martin (SD)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.
IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.

Laura J Gray (LJ)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.
IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.

Sean L McGee (SL)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.
IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.

Michael Berk (M)

IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
Orygen, the National Centre of Excellence in Youth Mental Health, The Department of Psychiatry and The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.

Ken Walder (K)

Centre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, Australia.
IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH